Identification of Palmitoleic Acid Controlled by mTOR Signaling as a Biomarker of Polymyositis

Polymyositis (PM) is a chronic disease characterized by muscle pain, weakness, and increase in muscle-related enzymes, accompanied with inflammations in lymphocytes. However, it is not well understood how the molecular alternations in lymphocytes contribute to the development of polymyositis. The me...

Full description

Saved in:
Bibliographic Details
Main Authors: Geng Yin, Ying Wang, Xiao-min Cen, Yuan Yang, Min Yang, Qi-bing Xie
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2017/3262384
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849409065832153088
author Geng Yin
Ying Wang
Xiao-min Cen
Yuan Yang
Min Yang
Qi-bing Xie
author_facet Geng Yin
Ying Wang
Xiao-min Cen
Yuan Yang
Min Yang
Qi-bing Xie
author_sort Geng Yin
collection DOAJ
description Polymyositis (PM) is a chronic disease characterized by muscle pain, weakness, and increase in muscle-related enzymes, accompanied with inflammations in lymphocytes. However, it is not well understood how the molecular alternations in lymphocytes contribute to the development of polymyositis. The mechanistic target of rapamycin (mTOR) signaling is the central regulator of metabolism and inflammation in mammalian cells. Based on previous studies, we proposed that mTOR signaling may control inflammatory reactions via lipid metabolism. In this study, we aim to figure out the role of mTOR signaling in the development of polymyositis and identify novel biomarkers for the detection and therapy of polymyositis. After screening and validation, we found that palmitoleic acid, a monounsaturated fatty acid, is highly regulated by mTOR signaling. Inhibition of mTORC1 activity decreases palmitoleic acid level. Moreover, mTORC1 regulates the level of palmitoleic acid by controlling its de novo synthesis. Importantly, increased palmitoleic acid has been proven to be a marker of polymyositis. Our work identifies palmitoleic acid in peripheral blood mononuclear cells (PBMC) as a biomarker of polymyositis and offers new targets to the clinical therapy.
format Article
id doaj-art-7762c5ff3bcb4e5d8cb3c1f64fd59580
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-7762c5ff3bcb4e5d8cb3c1f64fd595802025-08-20T03:35:37ZengWileyJournal of Immunology Research2314-88612314-71562017-01-01201710.1155/2017/32623843262384Identification of Palmitoleic Acid Controlled by mTOR Signaling as a Biomarker of PolymyositisGeng Yin0Ying Wang1Xiao-min Cen2Yuan Yang3Min Yang4Qi-bing Xie5Department of General Medicine, West China Hospital of Sichuan University, Chengdu 610041, ChinaDepartment of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu 610041, ChinaDepartment of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu 610041, ChinaDepartment of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu 610041, ChinaDepartment of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu 610041, ChinaDepartment of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu 610041, ChinaPolymyositis (PM) is a chronic disease characterized by muscle pain, weakness, and increase in muscle-related enzymes, accompanied with inflammations in lymphocytes. However, it is not well understood how the molecular alternations in lymphocytes contribute to the development of polymyositis. The mechanistic target of rapamycin (mTOR) signaling is the central regulator of metabolism and inflammation in mammalian cells. Based on previous studies, we proposed that mTOR signaling may control inflammatory reactions via lipid metabolism. In this study, we aim to figure out the role of mTOR signaling in the development of polymyositis and identify novel biomarkers for the detection and therapy of polymyositis. After screening and validation, we found that palmitoleic acid, a monounsaturated fatty acid, is highly regulated by mTOR signaling. Inhibition of mTORC1 activity decreases palmitoleic acid level. Moreover, mTORC1 regulates the level of palmitoleic acid by controlling its de novo synthesis. Importantly, increased palmitoleic acid has been proven to be a marker of polymyositis. Our work identifies palmitoleic acid in peripheral blood mononuclear cells (PBMC) as a biomarker of polymyositis and offers new targets to the clinical therapy.http://dx.doi.org/10.1155/2017/3262384
spellingShingle Geng Yin
Ying Wang
Xiao-min Cen
Yuan Yang
Min Yang
Qi-bing Xie
Identification of Palmitoleic Acid Controlled by mTOR Signaling as a Biomarker of Polymyositis
Journal of Immunology Research
title Identification of Palmitoleic Acid Controlled by mTOR Signaling as a Biomarker of Polymyositis
title_full Identification of Palmitoleic Acid Controlled by mTOR Signaling as a Biomarker of Polymyositis
title_fullStr Identification of Palmitoleic Acid Controlled by mTOR Signaling as a Biomarker of Polymyositis
title_full_unstemmed Identification of Palmitoleic Acid Controlled by mTOR Signaling as a Biomarker of Polymyositis
title_short Identification of Palmitoleic Acid Controlled by mTOR Signaling as a Biomarker of Polymyositis
title_sort identification of palmitoleic acid controlled by mtor signaling as a biomarker of polymyositis
url http://dx.doi.org/10.1155/2017/3262384
work_keys_str_mv AT gengyin identificationofpalmitoleicacidcontrolledbymtorsignalingasabiomarkerofpolymyositis
AT yingwang identificationofpalmitoleicacidcontrolledbymtorsignalingasabiomarkerofpolymyositis
AT xiaomincen identificationofpalmitoleicacidcontrolledbymtorsignalingasabiomarkerofpolymyositis
AT yuanyang identificationofpalmitoleicacidcontrolledbymtorsignalingasabiomarkerofpolymyositis
AT minyang identificationofpalmitoleicacidcontrolledbymtorsignalingasabiomarkerofpolymyositis
AT qibingxie identificationofpalmitoleicacidcontrolledbymtorsignalingasabiomarkerofpolymyositis